These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36672467)
21. Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses. Andersson M; Hashimi F; Lyrdal D; Lundstam S; Hellström M Acta Radiol; 2015 Dec; 56(12):1519-26. PubMed ID: 25414370 [TBL] [Abstract][Full Text] [Related]
22. [Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface]. Wu J; Lin S; Wu W; Yan K; Dai Q; Chen M Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):933-7. PubMed ID: 26887624 [TBL] [Abstract][Full Text] [Related]
23. Radiofrequency ablation of surface v/s intraparenchymal hepatocellular carcinoma in cirrhotic patients. Patidar Y; Singhal P; Gupta S; Mukund A; Sarin SK Indian J Radiol Imaging; 2017; 27(4):496-502. PubMed ID: 29379247 [TBL] [Abstract][Full Text] [Related]
24. Clinical application of contrast-enhanced ultrasound after percutaneous renal tumor ablation. Guo F; Hu B; Chen L; Li J Br J Radiol; 2019 Nov; 92(1103):20190183. PubMed ID: 31509441 [TBL] [Abstract][Full Text] [Related]
25. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up. Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665 [TBL] [Abstract][Full Text] [Related]
26. Percutaneous radiofrequency ablation of virtual tumours in canine kidney using Global Positioning System-like technology. Hung AJ; Ma Y; Zehnder P; Nakamoto M; Gill IS; Ukimura O BJU Int; 2012 May; 109(9):1398-403. PubMed ID: 21992738 [TBL] [Abstract][Full Text] [Related]
27. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results. Su Li; Jarrett TW; Chan DY; Kavoussi LR; Solomon SB Urology; 2003 Apr; 61(4 Suppl 1):26-33. PubMed ID: 12657358 [TBL] [Abstract][Full Text] [Related]
28. Percutanous and intraoperative ultrasound-guided radiofrequency ablation of hepatic tumours. Stang A; Keles H; von Seydewitz C; Hentschke S; Malzfeldt E; Teichmann W; Braumann D Ultraschall Med; 2007 Apr; 28(2):181-8. PubMed ID: 17447218 [TBL] [Abstract][Full Text] [Related]
29. Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications. del Cura JL; Zabala R; Iriarte JI; Unda M Eur Urol; 2010 Mar; 57(3):459-65. PubMed ID: 19926208 [TBL] [Abstract][Full Text] [Related]
30. Laparoscopic radiofrequency for small renal masses. What is the best imaging technique? Gallego Vilar D; Cifrian García M; García Fadrique G; García Vila J; Gallego Gómez J Arch Esp Urol; 2013; 66(1):60-70. PubMed ID: 23406801 [TBL] [Abstract][Full Text] [Related]
31. Percutaneous microwave ablation of renal masses in a UK cohort. John JB; Anderson M; Dutton T; Stott M; Crundwell M; Llewelyn R; Gemmell A; Bufacchi R; Spiers A; Campain N BJU Int; 2021 Apr; 127(4):486-494. PubMed ID: 32871034 [TBL] [Abstract][Full Text] [Related]
32. Long-Term Follow-Up Outcomes after Percutaneous US/CT-Guided Radiofrequency Ablation for cT1a-b Renal Masses: Experience from Single High-Volume Referral Center. Mauri G; Mistretta FA; Bonomo G; Camisassi N; Conti A; Vigna PD; Ferro M; Luzzago S; Maiettini D; Musi G; Piacentini N; Varano GM; Orsi OCAF Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32392792 [TBL] [Abstract][Full Text] [Related]
35. Radiofrequency ablation of small renal masses as an alternative to nephron-sparing surgery: preliminary results. Jasinski M; Siekiera J; Chlosta P; Mikolajczak W; Drewa T Wideochir Inne Tech Maloinwazyjne; 2011 Dec; 6(4):242-5. PubMed ID: 23255987 [TBL] [Abstract][Full Text] [Related]
36. Percutaneous RF thermal ablation of renal tumors: is US guidance really less favorable than other imaging guidance techniques? Veltri A; Garetto I; Pagano E; Tosetti I; Sacchetto P; Fava C Cardiovasc Intervent Radiol; 2009 Jan; 32(1):76-85. PubMed ID: 18709413 [TBL] [Abstract][Full Text] [Related]
37. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience. Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248 [TBL] [Abstract][Full Text] [Related]
38. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers. Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166 [TBL] [Abstract][Full Text] [Related]
39. Radiofrequency ablation (RFA) of T1a renal cancer with externally cooled multitined expandable electrodes. De Filippo M; Ziglioli F; Russo U; Pagano P; Brunese L; Bertelli E; Pagnini F; Maestroni U Radiol Med; 2020 Aug; 125(8):790-797. PubMed ID: 32206984 [TBL] [Abstract][Full Text] [Related]
40. [Percutaneous radiofrequency ablation of the renal tumors. Initial clinical experience with minimally invasive therapy]. Hoffmann P; Dvorák P; Morávek P; Safránek H Rozhl Chir; 2007 Sep; 86(9):494-9. PubMed ID: 17974143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]